Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations: A Prospective, Open-label, Cohort Study

NCT02764411 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02764411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02764411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations: A Prospective, Open-label, Cohort Study
Lead sponsor
The Hospital for Sick Children
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2016
Completion date
October 31, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

capillary malformations